[Better screening for work-related cancers: The experience of Brest University Hospital Occupational Disease Center inpatient service].

Abstract:

INTRODUCTION:An in-patient clinical service has been set up in March 2016 in the Occupational Diseases Center of Brest University Hospital, France, to seek for work-relatedness of diseases in patients hospitalized into the oncology and hematology departments. We present here data after two years of existence. METHODS:All cases of cancers or malignant hematological diseases (ICD-10 codes C00 to C97 and D37 to D48) seen between March 1, 2016, and March 1, 2018, have been identified. We present sociodemographic data, occupational exposures, occupation, business sector, and tobacco consumption. The causation level between the disease and each of the occupational exposures has been rated as strong, intermediate, weak or null by the occupational medicine specialist of the Occupational Diseases Center. RESULTS:Among the 196 patients encountered, there are 127 work-related diseases and 82 of these had one occupational exposure rated as strong or intermediate. The most frequent occupational hazards were asbestos (48 cases) and ionizing radiation (23 cases). The most frequent business sectors were metallurgy, mechanical engineering, and agriculture. Lung cancer was the most frequently reported disease (49 cases). DISCUSSION:. We identified well-known couples with occupational exposures and diseases, such as asbestos and lung cancer. We also identified a link between pesticides and leukemias. This in-patient clinical service is helpful to identify work-related exposures and in helping patients to get compensated.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Grignoux J,Loddé B,Dewitte JD,Larabi L,Durand-Moreau Q

doi

10.1016/j.bulcan.2020.01.013

subject

Has Abstract

pub_date

2020-04-01 00:00:00

pages

428-437

issue

4

eissn

0007-4551

issn

1769-6917

pii

S0007-4551(20)30117-X

journal_volume

107

pub_type

杂志文章
  • [Treatment of locally extensive soft tissue sarcomas. Value of intra-arterial chemotherapy (author's transl)].

    abstract::Between 1964 and 1978, 21 patients with locally extensive soft tissue sarcoma received intal-arterial regional chemotherapy (IAC), combined with radiotherapy. Some patients were also submitted to conservative surgery. Although there were three serious accidents, one of which was lethal, the tolerance was considered ac...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Marée D,Bui NB,Chauvergne J,Avril A,Richaud P

    更新日期:1980-01-01 00:00:00

  • [Breast tissue: estrogen receptors. Immunohistochemical and biochemical analysis of normal and hyperplastic tissue and carcinoma in situ. Apropos of 86 cases].

    abstract::Estrogen receptors (ER) were investigated using immunohistochemical techniques in 54 cases and biochemical techniques in 38 cases on a series of biopsy specimens of normal, hyperplasic and malignant mammary tissue (intraductal carcinoma). Immunohistochemical data were submitted to quantitative and semi-quantitative an...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Jacquemier J,Gandilhon PH,Charpin C,Pourreau-Schneider N,Hassoun J,Martin PM

    更新日期:1987-01-01 00:00:00

  • [Tamoxifen and endometrial adenocarcinoma].

    abstract::The authors report a case of endometrial carcinoma treated with tamoxifen introduced after normal initial uterine curettage. Based on recent experimental and clinical data, the importance of a gynecological follow-up in anti-estrogen therapy is emphasized. ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Rodier JF,Camus E,Janser JC,Renaud R,Rodier D

    更新日期:1990-01-01 00:00:00

  • [Cured after an intraocular tumor].

    abstract::We describe the psychological reactions after diagnosis and treatment of the malignant intraocular tumors: uveal melanoma and retinoblastoma. The chapter on uveal melanoma includes general consideration on the treatment of these tumors, the psychological effects on the patients, the professional and social problems, t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Desjardins L,Delage M,Lumbroso L,Levy C,Doz F

    更新日期:2001-11-01 00:00:00

  • [Stakes, aims and specificities of the physician-patient communication in cancer care: state of the art and perspectives].

    abstract::The physician-patient relationship has three main stakes : creating a high-quality inter-personal relationship, exchanging information and decision-making. The achievement of these stakes implies that the physician and the patient are able to reach specific communicational objectives. The aim of this paper is to revie...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Libert Y,Merckaert I,Reynaert C,Razavi D

    更新日期:2006-04-01 00:00:00

  • [Role of psychological factors in cancerogenesis and the development of cancerous disease].

    abstract::Psychoanalysts working in cancerology have to face three main difficulties concerning their methodology: the selection of representative populations, the identification of prospective factors and the choice and definition of the data they need to collect. Four examples are given hereafter: a prospective study on the p...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Raimbault E

    更新日期:1986-01-01 00:00:00

  • [Metastatic screening before adjuvant chemotherapy in breast cancer].

    abstract:INTRODUCTION:Systematic metastasis staging in early breast cancer is no longer recommended. However, it is still performed before adjuvant chemotherapy. MATERIALS AND METHODS:We assessed metastasis screening of asymptomatic women with a local breast cancer without lymph node involvement when adjuvant chemotherapy was ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2015.02.018

    authors: Thonnon C,Faure C,Chopin N,Beurrier F,Ho Quoc C,Tredan O,Carrabin N

    更新日期:2015-05-01 00:00:00

  • Biochemical aspects of chemical carcinogenesis.

    abstract::This article briefly outlines three major biochemical problems in relation to the presence of chemical carcinogens in mammalian cells: (a) the enzymatic systems responsible for the chemical carcinogen metabolism; (b) the nature of the reactive metabolites and (c) the cellular target(s). References and examples are onl...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Gielen JE

    更新日期:1978-01-01 00:00:00

  • Induction of hyperthermia by ultrasound.

    abstract::Induction of hyperthermia by ultrasound is facilitated by the characteristics of sound absorption in tissue: at frequency of 500 kHz the penetration distance in muscle is about 12.5 cm. Energy deposition patterns can be shaped by focussing or by the use of multiple transducers. An initial clinical study has demonstrat...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Hahn GM,Marmor JB,Pounds D

    更新日期:1981-01-01 00:00:00

  • [What future for circulating tumor DNA? Current data and prospects in colorectal, non-small cell lung and pancreatic cancers].

    abstract::Ten years after the discovery of the predictive value of KRAS status for anti-EGFR antibodies, other genes involved in oncogenesis and therapeutic responses were identified and are now systematically sought. Molecular diagnosis often requires invasive procedures, sometimes iatrogenic, and is limited by feasibility pro...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2015.10.017

    authors: Pietrasz D,Pécuchet N,Fabre E,Blons H,Chevalier L,Taly V,Laurent-Puig P,Bachet JB

    更新日期:2016-01-01 00:00:00

  • [Is AP24534 (Ponatinib) the next treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia?].

    abstract::Distinct clinicopathologic acute lymphoblastic leukemia (ALL) entities have been identified, resulting in the adoption of risk-oriented treatment approaches. In Philadelphia chromosome-positive (Ph(+)) ALL, the optimal treatment requires the addition of BCR-ABL tyrosine kinase inhibitors, as imatinib. However, the out...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2011.1390

    authors: Thomas X

    更新日期:2011-07-01 00:00:00

  • [Cytotoxicity of tamoxifen and its principal metabolites in human breast cancer cell lines].

    abstract::The antiestrogen tamoxifen (TAM) has been successfully used to treat breast cancer expressing estrogen and progesterone receptors (ER+ and PR+). However, the development of antiestrogen resistance is frequently observed in patients following long-term treatment. To better understand the mechanism of action of TAM and ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Bachmann-Moisson N,Barberi-Heyob M,Merlin JL,Ledrich ML,Batt AM,Guillemin F

    更新日期:1996-10-01 00:00:00

  • Determinants of 5-fluorouracil sensitivity in human tumors.

    abstract::It is not apparent that advanced human carcinomas of the breast or the large bowel are conprised of at least two populations: those responding to treatment with 5-fluorouracil (approximately 20 per cent) and those unresponsive to this drug. This classification cannot be made before chemotherapy on the basis of any cli...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Moran RG,Heidelberger C

    更新日期:1979-01-01 00:00:00

  • [Treatment of chronic myeloid leukemia in 2007].

    abstract::The treatment of chronic myeloid leukemia (CML) has considerably evolved since imatinib mesylate has been introduced as a new therapeutic weapon for this disease. The 5-year updated results of the IRIS study confirmed that imatinib mesylate is the best first line therapy for chronic phase CML with an overall survival ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Labussière H,Hayette S,Tigaud I,Michallet M,Nicolini FE

    更新日期:2007-10-01 00:00:00

  • [Integrins, cell response to anti-tumor agents and chemoresistance].

    abstract::Integrins are a family of heterodimeric transmembrane receptors that mediate cell-cell and cell-extracellular matrix adhesion. Integrin-mediated signaling is essential for the regulation of fundamental cellular functions, including proliferation and survival, and for tumor development. According to in vitro studies, i...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Maubant S,Staedel C,Gauduchon P

    更新日期:2002-11-01 00:00:00

  • [The problems raised by the irradiation of pregnant women. Effects of ionizing radiations on the embryon and foetus (author's transl)].

    abstract::In man, the period of maximum risk for the embryo and foetus is between the second and tenth week after conception. The most frequent and most severe malformation is microcephaly which in extreme cases is accompanied by mental retardation. The results of studies in experimental animals and man agree that it is impossi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Tubiana M

    更新日期:1979-01-01 00:00:00

  • [Imatinib in the treatment of chronic myeloid leukemia in Morocco].

    abstract:INTRODUCTION:The treatment of chronic myeloid leukemia (CML) has been revolutionized by the advent of tyrosine kinase inhibitors. The results of the IRIS trial demonstrated the efficacy and long-term safety profile of Imatinib. The objective of our work is to report the results at 15 years of treatment of CML in chroni...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2020.05.013

    authors: Dakkoune M,Qachouh M,Zoukal S,Hassoune S,Khoubila N,Cherkaoui S,Lamchahab M,Rachid M,Madani A,Quessar A

    更新日期:2020-09-01 00:00:00

  • [Doxifluridine toxicity, a fluorouracil analog with low myelosuppressive effect].

    abstract::Doxifluridine, a new fluorouracil analog with a low myelosuppressive effect, has recently been subject to various disease-oriented, Phase II trials. For the present evaluation of drug tolerance, the Phase II data of 114 patients having received 376 doxifluridine cycles has been used. The treatment cycles consisted of ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Winkelmann JJ,Alberto P,Mermillod B

    更新日期:1990-01-01 00:00:00

  • [Cancer of the prostate: estrogen therapy].

    abstract::From 1941, estrogens are usually used in the treatment of prostatic carcinoma, wrongly in case of adjuvant hormonotherapy and exceedingly because of cardiovascular toxicity from over dosages. A recall of their mechanism of action and toxicity allows to argue about the palliative treatment and to look to their use for ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Mauriac L,Richaud P,Mage P,Thomas L,Lamarche P

    更新日期:1986-01-01 00:00:00

  • [Retrospective study about 20 cases of ovarian Burkitt lymphoma at Yopougon teaching hospital in Côte d'Ivoire].

    abstract:CONTEXT:The maxillo-facial attack was the first described in the Burkitt lymphoma in 1958 by Denis Pearsons Burkitt. Abdominopelvic disorders, particularly ovarian localization are observed more and more by the developments of imagery technics. Our study aimed to describe the epidemiologic, clinical, therapeutic and ev...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/j.bulcan.2018.12.011

    authors: Kouakou B,Kamara I,Silue AD,Meite N,Botti RP,Tolo-Diebkile A,Sanogo I

    更新日期:2019-03-01 00:00:00

  • [Mechanisms and role of lymphangiogenesis in cancer metastasis].

    abstract::An important critical point in tumor progression is the acquisition of metastatic potential. The presence of metastases in regional lymph nodes is an indicator of poor survival. The vascular endothelial growth factor (VEGF) family of growth factors and receptors is involved in vasculogenesis and angiogenesis. Among th...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Dupuy E,Tobelem G

    更新日期:2003-07-01 00:00:00

  • [Sarcomas of soft tissue in the adult. Therapeutical indications].

    abstract::Treatment of soft-tissue sarcomas has to deal simultaneously with three goals: 1) to obtain the control of the primary tumor, 2) to preserve the function, and 3) to treat the micrometastatic disease. For local control, surgery remains the most efficient treatment, but the extent of the resection of macroscopically non...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Bui NB

    更新日期:1988-01-01 00:00:00

  • [Clinical development of anti-angiogenic agents in 2002].

    abstract::In 2002, new developments in anti-angiogenic strategies encompassed two main aspects. Firstly, essential improvements were made in the field of methodology : novel techniques permitted to measure directly on patients the biological effects induced by anti-angiogenic treatments in the course of clinical trials. Secondl...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Bachelot T,Jouanneau E,Blay JY

    更新日期:2003-01-01 00:00:00

  • [Evaluation of professional practices: improving cancer related-pain management in radiation oncology].

    abstract::Radiation oncologist often faced cancer pain, regardless the stage of cancer. Given the high prevalence of cancer pain, and its potential for profound adverse consequences, all patients with active malignancy should be routinely screened and treated for pain. Using a questionnaire developed by the pain center of the I...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2012.1630

    authors: Auberdiac P,Levy A,Guy JB,Malkoun N,Moncharmont C,Chargari C,Michaud P,De Laroche G,Magné N

    更新日期:2012-09-01 00:00:00

  • [DNA mismatch repair and BRAF status in colorectal cancer: Interest for the therapeutic management?].

    abstract::Colorectal cancer (CRC) is the second leading cause of cancer-related mortality in France. Recently, colorectal cancer subtyping consortium (CRCSC) identified 4 consensus molecular subtypes (CMS). CMS1 is enriched for CRC with deficient DNA mismatch repair system (dMMR) and tumors with mutated BRAF. Intriguingly, CMS1...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/S0007-4551(15)31220-0

    authors: Cohen R,Cervera P,Svrcek M,Dumont C,Garcia ML,Chibaudel B,de Gramont A,Pocard M,Duval A,Fléjou JF,André T

    更新日期:2015-06-01 00:00:00

  • [Cell cycle and molecular targets: CDK inhibition].

    abstract::Protein phosphorylation is a fundamental post-translational modification. It regulates a large number of critical cellular processes (differentiation, division, proliferation, apoptosis). Cell division is a process including a series of phases by which a parent cell divides into two daughter cells. The cells enter the...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2011.1383

    authors: Carassou P,Meijer L,Le Moulec S,Aoun J,Bengrine-Lefèvre L

    更新日期:2012-02-01 00:00:00

  • [Patients on oral anticancer drugs and coordinated pathway: CHIMORAL, feedback from care providers].

    abstract:INTRODUCTION:Oral anticancer drugs have raised the question of how to follow-up these patients and how to coordinate this follow-up. The CHIMORAL study evaluated the involvement of primary care providers and a coordination by territorial health networks. Training/information tools were provided, as well as weekly nursi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2020.08.014

    authors: Maritaz C,Napoly L,Burnel S,Lotz JP

    更新日期:2020-12-01 00:00:00

  • [Effectiveness of a supportive care form for family physicians].

    abstract::To assess the effectiveness of a standardized form in altering family physicians knowledge regarding supportive care delivered to their patients. We conducted an uncontrolled before and after study involving 42 cancer patients who were provided with supportive care at hospital. During the intervention study period, a ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2011.1452

    authors: Fouquereau J,Laval G,Labarère J

    更新日期:2011-10-01 00:00:00

  • [Li-Fraumeni syndrome].

    abstract::The Li-Fraumeni syndrome is an autosomal dominant syndrome representing a genetic predisposition to a wide spectrum of tumours including sarcomas, breast carcinomas, brain tumors and adrenocortical carcinomas. In most of the cases, tumours will develop in children and young adults. Germline mutations of the tumor supp...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Frebourg T

    更新日期:1997-07-01 00:00:00

  • [The cost of radiotherapy].

    abstract::The higher human and material costs induced by the development of conformal radiotherapy and other innovative techniques have to be evaluated. Different studies reflect benefit for three-dimensional conformal radiation therapy. This needs appropriate economic analyses (cost/benefit, cost/utility). Conclusions from stu...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Martin P

    更新日期:2003-11-01 00:00:00